| From: |
|
Dr June Raine, Chief Executive
|
|
|
- NHS Regional Offices
- NHS Foundation Trusts (England) - Medical Director
- NHS Foundation Trusts (England) - Chief Executive
- NHS Trusts (England) - Medical Director
- NHS Trusts (England) - Chief Executive
|
|
|
- MHRA (Medicines) Drug Alerts (Various Recipients)
- Other contacts
- Independent Healthcare Providers (registered with CAS)
- Clinical Commissioning Groups
- Social Care Providers (registered with CAS)
- Special Health Authorities
- CMO Urgent Messages - Non-NHS Recipients on Public Health Link
- MHRA (Medicines) Drug Alerts - Non-NHS Recipients
- Territorial CMOs in Northern Ireland, Scotland & Wales
- Regional Directors of Public Health
- Consultants in Communicable Diseases
- CMO Urgent Messages - Recipients on Public Health Link
- Director of Public Health
- GP - Locum
- NHS 111 and Out of hours providers
- GP Practices
- DHSC Supply Disruption - Medicines
- Primary Care Networks
|
| Action category: |
|
Important information for immediate action
|
| Title: |
|
Yellow Card reporting site for healthcare products used in Coronavirus (COVID-19)
|
| Broadcast content: |
|
The Medicines and Healthcare products
Regulatory Agency (MHRA) has launched a dedicated Yellow Card reporting site
for healthcare products that are used in Coronavirus (COVID-19) treatment to be
easily reported: coronavirus-yellowcard.mhra.gov.uk
Healthcare professionals, patients and carers are asked to report all
suspected side effects to medicines or medical device adverse incidents related to COVID-19 treatment.
|
| Additional information: |
|
NHS England Regional Offices: please cascade to Community Pharmacy, Dental and Optometry contractors and any GP Practices not yet registered with CAS.
|